Peter Libby
Brigham and Women's Hospital(US)Harvard University(US)Mount Sinai Hospital(US)Center for Vascular Biology Research(US)
Publications by Year
Research Areas
Inflammatory mediators and NSAID effects, Antiplatelet Therapy and Cardiovascular Diseases, Atherosclerosis and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Cell Adhesion Molecules Research
Most-Cited Works
- → Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis(2016)837 cited
- → Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.(1988)530 cited
- → Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque(1995)373 cited
- → Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor(2002)338 cited
- → Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis(2009)121 cited
- → Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial